Lercanidipine is an effective and well tolerated antihypertensive drug regardless the cardiovascular risk profile: The LAURA study
about
Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidenceEnantioselectivity in the pharmacokinetic interaction between fluvastatin and lercanidipine in healthy volunteers.Emerging drug combinations to optimize renovascular protection and blood pressure goals.Fixed combination of lercanidipine and enalapril in the management of hypertension: focus on patient preference and adherence.High doses of lercanidipine are better tolerated than other dihydropyridines in hypertensive patients with metabolic syndrome: results from the TOLERANCE study.Hypertension, possible vascular protection and lercanidipine.Fixed combinations in the management of hypertension: perspectives on lercanidipine-enalaprilFixed-combination therapies in hypertension management: focus on enalapril/lercanidipine.The role of fixed-dose combinations in the management of hypertension: focus on lercanidipine-enalapril.Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?Anti-inflammatoryactivity of calciumchannel blocker lercanidipine hydrochloride.Low-dose fixed combination of perindopril plus indapamide in the diabetic hypertensive population.Lercanidipine in the Management of Hypertension: An Update.
P2860
Q28074644-F717A8AA-3864-4660-A930-2F25AAD820F1Q34657726-0B58E892-B0FC-4BEC-9E2D-1520FF153800Q35905899-AA756239-4BE5-4B8B-ADC0-868DDC0DFB4DQ36085768-2EB1E995-CA5D-4588-B979-46454F2A54E4Q36573484-94BC578E-D27A-44FD-BB81-8A0E73D4ADB7Q36686030-D29BB52E-C491-41C0-88A4-61961EBCF36AQ37004035-777D15E6-631C-4A92-BC0D-97BB0AE64CC5Q37390740-D48D26CF-D048-428A-9700-25D2CB431ACAQ37519741-54C40B02-E82A-4DB7-9841-9E73D190B72CQ37556555-CA95E25A-2277-419B-941A-31C0A1E61807Q42909920-241B7B70-7DA9-43B4-BA4B-58706873BB28Q46366858-0EFC22FE-2951-4BD9-A092-BCC8AA3C6E73Q52689065-60A19E92-AF65-46EB-8610-4D01C323CF59
P2860
Lercanidipine is an effective and well tolerated antihypertensive drug regardless the cardiovascular risk profile: The LAURA study
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Lercanidipine is an effective ...... risk profile: The LAURA study
@ast
Lercanidipine is an effective ...... risk profile: The LAURA study
@en
Lercanidipine is an effective ...... risk profile: The LAURA study
@nl
type
label
Lercanidipine is an effective ...... risk profile: The LAURA study
@ast
Lercanidipine is an effective ...... risk profile: The LAURA study
@en
Lercanidipine is an effective ...... risk profile: The LAURA study
@nl
prefLabel
Lercanidipine is an effective ...... risk profile: The LAURA study
@ast
Lercanidipine is an effective ...... risk profile: The LAURA study
@en
Lercanidipine is an effective ...... risk profile: The LAURA study
@nl
P2093
P2860
P1476
Lercanidipine is an effective ...... risk profile: The LAURA study
@en
P2093
A Calderón
J Navarro-Cid
P2860
P304
P356
10.1111/J.1742-1241.2006.01176.X
P407
P577
2006-11-01T00:00:00Z